Synopsis Amiodarone, originally developed over 20 years ago, is a potent antiarrhythmic
drug with the actions of all antiarrhythmic drug classes. It has been successfully used in the …

Amiodarone is a unique antiarrhythmic agent originally developed as a vasodilator.
Classified electrophysiologically as a Type III antiarrhythmic, it also has both nonspecific …

Improvement of patient functional status is an important goal in the therapy of cardiovascular
disease. Given the pressures on the medical profession to restrain the growth of health care …

Parenteral magnesium sulfate versus amiodarone in the therap... : Critical Care Medicine
Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: A …

Class III antiarrhythmic drugs, especially amiodarone (a broad-spectrum antiarrhythmic
agent), have gained popularity for use in clinical practice in recent years. Other class III …

Objective To compare the efficacy and safety of intravenous (IV) amiodarone and
procainamide for the treatment of atrial tachyarrhythmias (AT) in the critically ill. Design In …

Amiodarone hydrochloride is increasingly being used in the treatment of ventricular and
supraventricular arrhythmias. Although a highly effective anti-arrhythmic agent, its use is …

Hepatic enzymes, pulmonary function, serum amiodarone and desethylamiodarone (DEA)
concentrations and erythrocyte superoxide dismutase (SOD) activity were monitored at …

The potential modes of sudden death in hypertrophic cardiomyopathy (HC) can be broadly
divided into those in which arrhythmia is the primary cause and those in which initial …

Problems with pulmonary toxicity have emerged as a potentially limiting factor for
amiodarone use. We studied 24 consecutive patients receiving low-dose (ie,≤ 400 mg/day) …